Share-based Payment Arrangement, Expense in USD of NEVRO CORP from 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NEVRO CORP quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2012 to Q4 2024.
  • NEVRO CORP Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2024 was $12.5M, a 8.15% decline year-over-year.
  • NEVRO CORP Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2024 was $51.2M, a 9.98% decline year-over-year.
  • NEVRO CORP annual Share-based Payment Arrangement, Expense for 2024 was $51.2M, a 9.98% decline from 2023.
  • NEVRO CORP annual Share-based Payment Arrangement, Expense for 2023 was $56.9M, a 0.12% increase from 2022.
  • NEVRO CORP annual Share-based Payment Arrangement, Expense for 2022 was $56.8M, a 28% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

NEVRO CORP Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $51.2M $12.5M -$1.11M -8.15% 01 Oct 2024 31 Dec 2024 10-K 04 Mar 2025
Q3 2024 $52.3M $11.4M -$2.1M -15.5% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $54.4M $14.4M -$1.75M -10.8% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $56.1M $12.8M -$722K -5.32% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $56.9M $13.6M -$1.19M -8.04% 01 Oct 2023 31 Dec 2023 10-K 04 Mar 2025
Q3 2023 $58.1M $13.5M -$1.68M -11.1% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $59.7M $16.2M +$2.79M +20.8% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $57M $13.6M +$152K +1.13% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 $56.8M $14.8M 01 Oct 2022 31 Dec 2022 10-K 04 Mar 2025
Q3 2022 $15.2M 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 $13.4M 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023
Q1 2022 $13.4M 01 Jan 2022 31 Mar 2022 10-Q 26 Apr 2023
Q3 2014 $436K +$13K +3.07% 01 Jul 2014 30 Sep 2014 10-Q 02 Dec 2014
Q3 2013 $423K 01 Jul 2013 30 Sep 2013 10-Q 02 Dec 2014

NEVRO CORP Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $51.2M -$5.68M -9.98% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025
2023 $56.9M +$67K +0.12% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025
2022 $56.8M +$12.4M +28% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025
2021 $44.4M +$1.71M +4.01% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024
2020 $42.7M +$958K +2.3% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023
2019 $41.7M +$5.06M +13.8% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022
2018 $36.6M +$10.5M +40.1% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021
2017 $26.1M +$10.4M +65.9% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 $15.8M +$8.44M +115% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019
2015 $7.33M +$5.33M +267% 01 Jan 2015 31 Dec 2015 10-K 22 Feb 2018
2014 $2M +$398K +24.9% 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017
2013 $1.6M +$475K +42.2% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 $1.13M 01 Jan 2012 31 Dec 2012 10-K 18 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.